I’ve been reading many criticisms about the massaging of the data and selection bias in the Seroprevalence Study.
So let’s say due to the flaws the multiplier is not 40-80x. Let’s say it’s more in the neighborhood of 15-25x.
I am not advocating re-opening. If NYC now has significant immunity (15%? 20%). I don’t think they want to go through what they went through 3 or 4 more times.
But there are significant implications. A 15-25x is still a lot higher than I thought it would be. If say 2% of the local Santa Clara County population is immune, you can conceive of say, shifting immune healthcare workers to work at senior assisted living facilities in a way that would have been less practical if only .1% of the population had immunity (if in fact antibodies confer immunity).
So let’s say due to the flaws the multiplier is not 40-80x. Let’s say it’s more in the neighborhood of 15-25x.
I am not advocating re-opening. If NYC now has significant immunity (15%? 20%). I don’t think they want to go through what they went through 3 or 4 more times.
But there are significant implications. A 15-25x is still a lot higher than I thought it would be. If say 2% of the local Santa Clara County population is immune, you can conceive of say, shifting immune healthcare workers to work at senior assisted living facilities in a way that would have been less practical if only .1% of the population had immunity (if in fact antibodies confer immunity).
